AJANTA PHARMA
|
AJANTA PHARMA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr | ₹17 Cr |
| Equity - Authorised | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr | ₹30 Cr |
| Equity - Issued | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr | ₹17 Cr |
| Equity Paid Up | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹17 Cr | ₹17 Cr |
| Equity Shares Forfeited | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr | ₹0.09 Cr |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | ₹5.18 Cr | ₹5.65 Cr | ₹0.34 Cr | ₹0.30 Cr | ₹0.54 Cr |
| Total Reserves | ₹3,760 Cr | ₹3,536 Cr | ₹3,362 Cr | ₹3,247 Cr | ₹2,978 Cr |
| Securities Premium | ₹3.66 Cr | ₹0.18 Cr | - | - | - |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹3,672 Cr | ₹3,314 Cr | ₹3,141 Cr | ₹2,718 Cr | ₹2,156 Cr |
| General Reserves | ₹72 Cr | ₹211 Cr | ₹211 Cr | ₹532 Cr | ₹817 Cr |
| Other Reserves | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹-2.60 Cr | ₹5.14 Cr |
| Reserve excluding Revaluation Reserve | ₹3,760 Cr | ₹3,536 Cr | ₹3,362 Cr | ₹3,247 Cr | ₹2,978 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹3,790 Cr | ₹3,567 Cr | ₹3,388 Cr | ₹3,264 Cr | ₹2,996 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | ₹1.25 Cr | ₹1.64 Cr | ₹1.60 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | ₹1.25 Cr | ₹1.64 Cr | ₹1.60 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-76 Cr | ₹-26 Cr | ₹0.95 Cr | ₹46 Cr | ₹42 Cr |
| Deferred Tax Assets | ₹224 Cr | ₹169 Cr | ₹131 Cr | ₹84 Cr | ₹60 Cr |
| Deferred Tax Liability | ₹148 Cr | ₹144 Cr | ₹132 Cr | ₹130 Cr | ₹102 Cr |
| Other Long Term Liabilities | ₹38 Cr | ₹27 Cr | ₹29 Cr | ₹21 Cr | ₹23 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹80 Cr | ₹40 Cr | ₹147 Cr | ₹216 Cr | ₹208 Cr |
| Total Non-Current Liabilities | ₹42 Cr | ₹41 Cr | ₹177 Cr | ₹285 Cr | ₹275 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹454 Cr | ₹463 Cr | ₹423 Cr | ₹327 Cr | ₹374 Cr |
| Sundry Creditors | ₹454 Cr | ₹463 Cr | ₹423 Cr | ₹327 Cr | ₹374 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹478 Cr | ₹370 Cr | ₹669 Cr | ₹301 Cr | ₹214 Cr |
| Bank Overdraft / Short term credit | ₹3.50 Cr | ₹1.56 Cr | ₹3.84 Cr | ₹9.49 Cr | ₹6.39 Cr |
| Advances received from customers | ₹74 Cr | ₹39 Cr | ₹10 Cr | ₹52 Cr | ₹21 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹401 Cr | ₹329 Cr | ₹656 Cr | ₹240 Cr | ₹187 Cr |
| Short Term Borrowings | - | - | - | - | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | - | - | - | - |
| Short Term Provisions | ₹64 Cr | ₹63 Cr | ₹47 Cr | ₹19 Cr | ₹251 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹41 Cr | ₹45 Cr | ₹33 Cr | ₹7.94 Cr | ₹239 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹23 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr | ₹12 Cr |
| Total Current Liabilities | ₹996 Cr | ₹895 Cr | ₹1,139 Cr | ₹647 Cr | ₹839 Cr |
| Total Liabilities | ₹4,829 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr | ₹4,109 Cr |
| ASSETS | |||||
| Gross Block | ₹2,801 Cr | ₹2,389 Cr | ₹2,283 Cr | ₹2,207 Cr | ₹2,130 Cr |
| Less: Accumulated Depreciation | ₹1,039 Cr | ₹910 Cr | ₹786 Cr | ₹703 Cr | ₹598 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,762 Cr | ₹1,479 Cr | ₹1,496 Cr | ₹1,504 Cr | ₹1,532 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹176 Cr | ₹256 Cr | ₹209 Cr | ₹153 Cr | ₹108 Cr |
| Non Current Investments | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr | - |
| Long Term Investment | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr | - |
| Quoted | - | - | - | - | - |
| Unquoted | ₹25 Cr | ₹19 Cr | ₹25 Cr | ₹25 Cr | - |
| Long Term Loans & Advances | ₹18 Cr | ₹14 Cr | ₹135 Cr | ₹236 Cr | ₹231 Cr |
| Other Non Current Assets | ₹3.71 Cr | ₹4.37 Cr | ₹4.85 Cr | ₹5.88 Cr | ₹11 Cr |
| Total Non-Current Assets | ₹1,985 Cr | ₹1,773 Cr | ₹1,871 Cr | ₹1,932 Cr | ₹1,891 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹439 Cr | ₹330 Cr | ₹510 Cr | ₹122 Cr | ₹176 Cr |
| Quoted | ₹429 Cr | ₹299 Cr | ₹386 Cr | ₹122 Cr | ₹139 Cr |
| Unquoted | ₹10 Cr | ₹31 Cr | ₹124 Cr | - | ₹37 Cr |
| Inventories | ₹904 Cr | ₹828 Cr | ₹816 Cr | ₹791 Cr | ₹766 Cr |
| Raw Materials | ₹281 Cr | ₹233 Cr | ₹264 Cr | ₹240 Cr | ₹291 Cr |
| Work-in Progress | ₹46 Cr | ₹54 Cr | ₹52 Cr | ₹47 Cr | ₹48 Cr |
| Finished Goods | ₹192 Cr | ₹171 Cr | ₹189 Cr | ₹180 Cr | ₹146 Cr |
| Packing Materials | ₹50 Cr | ₹55 Cr | ₹52 Cr | ₹49 Cr | ₹58 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹335 Cr | ₹315 Cr | ₹258 Cr | ₹275 Cr | ₹223 Cr |
| Sundry Debtors | ₹1,183 Cr | ₹1,247 Cr | ₹1,057 Cr | ₹1,020 Cr | ₹738 Cr |
| Debtors more than Six months | ₹23 Cr | ₹31 Cr | ₹27 Cr | ₹21 Cr | ₹10 Cr |
| Debtors Others | ₹1,166 Cr | ₹1,225 Cr | ₹1,041 Cr | ₹1,014 Cr | ₹742 Cr |
| Cash and Bank | ₹176 Cr | ₹131 Cr | ₹331 Cr | ₹212 Cr | ₹210 Cr |
| Cash in hand | - | ₹0.01 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹0.03 Cr |
| Balances at Bank | ₹176 Cr | ₹131 Cr | ₹331 Cr | ₹212 Cr | ₹210 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹39 Cr | ₹54 Cr | ₹22 Cr | ₹35 Cr | ₹52 Cr |
| Interest accrued on Investments | ₹2.29 Cr | ₹6.54 Cr | ₹2.48 Cr | ₹0.58 Cr | ₹1.76 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹25 Cr | ₹26 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr |
| Other current_assets | ₹12 Cr | ₹21 Cr | ₹3.17 Cr | ₹19 Cr | ₹36 Cr |
| Short Term Loans and Advances | ₹89 Cr | ₹132 Cr | ₹89 Cr | ₹85 Cr | ₹276 Cr |
| Advances recoverable in cash or in kind | ₹60 Cr | ₹76 Cr | ₹47 Cr | ₹39 Cr | ₹31 Cr |
| Advance income tax and TDS | - | - | - | - | ₹190 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹30 Cr | ₹56 Cr | ₹42 Cr | ₹47 Cr | ₹55 Cr |
| Total Current Assets | ₹2,830 Cr | ₹2,722 Cr | ₹2,825 Cr | ₹2,264 Cr | ₹2,218 Cr |
| Net Current Assets (Including Current Investments) | ₹1,834 Cr | ₹1,827 Cr | ₹1,686 Cr | ₹1,617 Cr | ₹1,379 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹4,829 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr | ₹4,109 Cr |
| Contingent Liabilities | ₹8.12 Cr | ₹4.42 Cr | ₹4.03 Cr | ₹6.76 Cr | ₹82 Cr |
| Total Debt | ₹2.59 Cr | ₹1.49 Cr | ₹1.43 Cr | ₹1.91 Cr | ₹1.69 Cr |
| Book Value | - | 282.89 | 269.07 | 382.20 | 346.24 |
| Adjusted Book Value | 303.04 | 282.89 | 269.07 | 254.80 | 230.83 |
Compare Balance Sheet of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹30,179.6 Cr | -2.3% | -4.9% | -23.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,248.0 Cr | 1.8% | 2.7% | -11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,177.0 Cr | -0.6% | 7.7% | 9.4% | Stock Analytics | |
| CIPLA | ₹132,898.0 Cr | 4.9% | 6.7% | 7.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,428.0 Cr | 2.4% | -1% | 4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,818.0 Cr | 3.2% | -1.7% | -4.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2.3% |
-4.9% |
-23.3% |
| SENSEX | 2.4% |
2.3% |
4.4% |
You may also like the below Video Courses